The metabolism of Α-tocopherol (Α-TOH, vitamin E) shows marked interindividual variability, which may influence the response to nutritional and therapeutic interventions with this vitamin. Recently, new metabolomics protocols have fostered the possibility to explore such variability for the different metabolites of Α-TOH so far identified in human blood, i.e., the “vitamin E metabolome”, some of which have been reported to promote important biological functions. Such advances prompt the definition of reference values and degree of interindividual variability for these metabolites at different levels of Α-TOH intake. To this end, a one-week oral administration protocol with 800 U RRR-Α-TOH/day was performed in 17 healthy volunteers, and Α-TOH metabolites were measured in plasma before and at the end of the intervention utilizing a recently validated LC-MS/MS procedure; the expression of two target genes of Α-TOH with possible a role in the metabolism and function of this vitamin, namely pregnane X receptor (PXR) and the isoform 4F2 of cytochrome P450 (CYP4F2) was assessed by immunoblot in peripheral blood leukocytes. The levels of enzymatic metabolites showed marked interindividual variability that characteristically increased upon supplementation. With the exception of Α-CEHC (carboxy-ethyl-hydroxychroman) and the long-chain metabolites M1 and Α-13‘OH, such variability was found to interfere with the possibility to utilize them as sensitive indicators of Α-TOH intake. On the contrary, the free radicalderived metabolite Α-tocopheryl quinone significantly correlated with the post-supplementation levels of Α-TOH. The supplementation stimulated PXR, but not CYP4F2, expression of leucocytes, and significant correlations were observed between the baseline levels of Α-TOH and both the baseline and post-supplementation levels of PXR. These findings provide original analytical and molecular information regarding the human metabolism of Α-TOH and its intrinsic variability, which is worth considering in future nutrigenomics and interventions studies.
Alpha-tocopherol metabolites (the vitamin E metabolome) and their interindividual variability during supplementation
Bartolini D.
;Marinelli R.;Galarini R.;Stabile A. M.;Sebastiani B.;Betti M.;Rende M.;Galli F.
2021
Abstract
The metabolism of Α-tocopherol (Α-TOH, vitamin E) shows marked interindividual variability, which may influence the response to nutritional and therapeutic interventions with this vitamin. Recently, new metabolomics protocols have fostered the possibility to explore such variability for the different metabolites of Α-TOH so far identified in human blood, i.e., the “vitamin E metabolome”, some of which have been reported to promote important biological functions. Such advances prompt the definition of reference values and degree of interindividual variability for these metabolites at different levels of Α-TOH intake. To this end, a one-week oral administration protocol with 800 U RRR-Α-TOH/day was performed in 17 healthy volunteers, and Α-TOH metabolites were measured in plasma before and at the end of the intervention utilizing a recently validated LC-MS/MS procedure; the expression of two target genes of Α-TOH with possible a role in the metabolism and function of this vitamin, namely pregnane X receptor (PXR) and the isoform 4F2 of cytochrome P450 (CYP4F2) was assessed by immunoblot in peripheral blood leukocytes. The levels of enzymatic metabolites showed marked interindividual variability that characteristically increased upon supplementation. With the exception of Α-CEHC (carboxy-ethyl-hydroxychroman) and the long-chain metabolites M1 and Α-13‘OH, such variability was found to interfere with the possibility to utilize them as sensitive indicators of Α-TOH intake. On the contrary, the free radicalderived metabolite Α-tocopheryl quinone significantly correlated with the post-supplementation levels of Α-TOH. The supplementation stimulated PXR, but not CYP4F2, expression of leucocytes, and significant correlations were observed between the baseline levels of Α-TOH and both the baseline and post-supplementation levels of PXR. These findings provide original analytical and molecular information regarding the human metabolism of Α-TOH and its intrinsic variability, which is worth considering in future nutrigenomics and interventions studies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
